TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes (Q33829240)

29 July 2017

title

TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes (English)

1 reference

29 July 2017

1 reference

Michael Stumvoll

1 reference

29 July 2017

Antje Körner

0 references

Peter Kovacs

1 reference

29 July 2017

Andreas Holstein

1 reference

29 July 2017

Michael Hahn

series ordinal

1 reference

29 July 2017

publication date

24 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

TCF7L2: the biggest story in diabetes genetics since HLA?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Association of Transcription Factor 7-Like 2 (TCF7L2) Variants With Type 2 Diabetes in a Finnish Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Transcription Factor TCF7L2 Genetic Study in the French Population: Expression in Human -Cells and Adipose Tissue and Strong Association With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Utilization of oral hypoglycemic agents in a drug-insured U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Gene association studies in acute lung injury: replication and future direction

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051886

TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels

29 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-30

Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349175

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2350-12-30

1 reference

29 July 2017

1 reference

29 July 2017

1 reference